O. James Sterling - 01 Jul 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Financial Officer
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
03 Jul 2024, 16:05:20 UTC
Previous filing
13 Jun 2024
Next filing
02 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Options (Right to buy) Award $0 +300,000 $0.000000 300,000 01 Jul 2024 Common Stock 300,000 $0.9800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests over a four-year period at the rate of 25% on July 1, 2025, and then in equal monthly installments for the remaining 36 months.